Skilarence 30 mg, 120 mg gastro-resisistant tablets

  • Name:

    Skilarence 30 mg, 120 mg gastro-resisistant tablets

  • Company:
    info
  • Active Ingredients:

    Dimethyl fumarate

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 15/10/20

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 15/10/2020

Click on this link to Download PDF directly

Almirall Limited

Large-ALM_AW_LOGO_MV_Positive_CMYK_1579525802

Company Products

Medicine NameActive Ingredients
Medicine Name Almogran 12.5 mg Film-coated tablet Active Ingredients Almotriptan D, L-hydrogen malate
Medicine Name Ilumetri 100 mg solution for injection in pre-filled syringe Active Ingredients Tildrakizumab
Medicine Name Meptid 100 mg/ml Solution for Injection Active Ingredients Meptazinol hydrochloride
Medicine Name Meptid 200 mg Film-Coated Tablets Active Ingredients Meptazinol hydrochloride
Medicine Name Skilarence 30 mg gastro-resistant tablets Active Ingredients Dimethyl fumarate
Medicine Name Skilarence 30 mg, 120 mg gastro-resisistant tablets Active Ingredients Dimethyl fumarate
Medicine Name Solaraze 3% Gel Active Ingredients Diclofenac Sodium
Medicine Name Vaniqa 11.5% cream Active Ingredients Eflornithine hydrochloride monohydrate
1 - 0 of 8 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 15 October 2020 PIL

Reasons for updating

  • Change to section 4 - possible side effects

Free text change information supplied by the pharmaceutical company

Additional side effect with frequency unknown: herpes zoster

Updated on 15 October 2020 SPC

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Section 4.8 - additional side effect - Herpes zoster

Removal of astericks to indicate that the following side effects have also been reported for Skilarence:

PML, abdominal distention, allergic skin reaction, proteinuria, renal failure, serum creatininine increased.

Updated on 18 November 2019 Ed-HCP

Reasons for updating

  • Replace document

Free text change information supplied by the pharmaceutical company

Update of email address for queries

Updated on 22 August 2019 SPC

Reasons for updating

  • New SPC for new product

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Addition of 70 and 120 tablet pack size for the 30 mg strength.

Updated on 13 February 2019 Ed-HCP

Reasons for updating

  • Add New Doc

Updated on 30 January 2019 PIL

Reasons for updating

  • New PIL for new product